Literature DB >> 24059310

How do periodontal infections affect the onset and progression of Alzheimer's disease?

Munvar M Shaik, Sultan Ahmad, Siew H Gan, Adel M Abuzenadah, Ejaz Ahmad, Shams Tabrez, Farid Ahmed, Mohammad A Kamal1.   

Abstract

Chronic infection can cause slow progressive dementia, cortical atrophy and amyloid deposition in the atrophic form of general paresis. Due to the fact that specific bacterial ligands can increase the expression of proinflammatory molecules that can activate innate and adaptive immune systems, inflammation may play a significant role in the pathogenesis of Alzheimer's disease (AD). Furthermore, there is a significant association between AD and various types of spirochete. Periodontitis is a prevalent and persistent peripheral infection that is associated with gram-negative anaerobic bacteria and is capable of showing localized and systemic infections in the host. Periodontal disease related pathogens and their inflammatory products contribute to systemic inflammation and the pathogenesis of AD. In this minireview, we propose a hypothetical link between periodontitis, type 2 diabetes and AD. We also present the possible mechanistic links between periodontitis-related inflammation, type 2 diabetes and AD. Since this condition is treatable, periodontitis may be a readily-modifiable risk factor for AD.

Entities:  

Mesh:

Year:  2014        PMID: 24059310     DOI: 10.2174/18715273113126660152

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  9 in total

1.  Systemic diseases: periodontitis and Alzheimer's.

Authors:  A Dziedzic
Journal:  Br Dent J       Date:  2014-07       Impact factor: 1.626

2.  A Pilot Study to Evaluate the Oral Microbiome and Dental Health in Primary Open-Angle Glaucoma.

Authors:  Daniel Polla; Konstantin Astafurov; Eman Hawy; Leslie Hyman; Wei Hou; John Danias
Journal:  J Glaucoma       Date:  2017-04       Impact factor: 2.503

Review 3.  Gingimaps: Protein Localization in the Oral Pathogen Porphyromonas gingivalis.

Authors:  Giorgio Gabarrini; Stefano Grasso; Arie Jan van Winkelhoff; Jan Maarten van Dijl
Journal:  Microbiol Mol Biol Rev       Date:  2020-01-02       Impact factor: 11.056

4.  Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.

Authors:  Tamàs Fülöp; Usma Munawara; Anis Larbi; Mathieu Desroches; Serafim Rodrigues; Michele Catanzaro; Andrea Guidolin; Abdelouahed Khalil; François Bernier; Annelise E Barron; Katsuiku Hirokawa; Pascale B Beauregard; David Dumoulin; Jean-Philippe Bellenger; Jacek M Witkowski; Eric Frost
Journal:  CNS Drugs       Date:  2020-07       Impact factor: 6.497

5.  Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS).

Authors:  Janette Bester; Prashilla Soma; Douglas B Kell; Etheresia Pretorius
Journal:  Oncotarget       Date:  2015-11-03

6.  Porphyromonas gingivalis, a periodontitis causing bacterium, induces memory impairment and age-dependent neuroinflammation in mice.

Authors:  Ye Ding; Jingyi Ren; Hongqiang Yu; Weixian Yu; Yanmin Zhou
Journal:  Immun Ageing       Date:  2018-01-30       Impact factor: 6.400

Review 7.  Do epigenetic changes caused by commensal microbiota contribute to development of ocular disease? A review of evidence.

Authors:  Ashima Nayyar; Sofya Gindina; Arturo Barron; Yan Hu; John Danias
Journal:  Hum Genomics       Date:  2020-03-13       Impact factor: 4.639

8.  Gingipain R1 and Lipopolysaccharide From Porphyromonas gingivalis Have Major Effects on Blood Clot Morphology and Mechanics.

Authors:  J Massimo Nunes; Tristan Fillis; Martin J Page; Chantelle Venter; Ophélie Lancry; Douglas B Kell; Ursula Windberger; Etheresia Pretorius
Journal:  Front Immunol       Date:  2020-07-24       Impact factor: 7.561

9.  The Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type Dementia.

Authors:  Etheresia Pretorius; Janette Bester; Martin J Page; Douglas B Kell
Journal:  Front Aging Neurosci       Date:  2018-08-22       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.